St. Paul, MN · Health Care · Form D filed Sep 25, 2026

EyeMacular Regeneration, Inc. raised $2.9M

EyeMacular Regeneration, Inc. is a biotechnology company based in St. Paul, Minnesota. In an amended Form D filed with the SEC on September 25, 2026, it reported raising $2,870,000 from 14 investors as part of an offering of up to $6,000,000. The first sale in the offering took place on October 8, 2024.

View the SEC filing Find on LinkedIn People at this company

2nd Form D since 2024. Earlier new notices: Oct 24, 2024. All filings on EDGAR
Still raising. $3.1M of the $6M offering was still unsold at filing.

$2.9M raised since 2020

1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.

Filed	Sold	Offering size	Investors
Oct 24, 2024	$2.9M	$6M	14

Lead score

37 out of 100

filed recently early raise still raising budget to spend young company

Outreach kit How it works 1:21

A first message that shows you did your homework, written from this filing. Fill in the brackets and send.

Email · subject: Congrats on the new round

Hi [first name],

Congrats on the new round. I saw the raise in your SEC filing.

Teams at this stage usually start looking at [what you do] right after a round...

[Your name]

LinkedIn note

Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?

Call opener

Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...

Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing

Track this company How it works 0:56

Saved to your dashboard pipeline, with a badge in Explore.

Loading your outreach kit…

The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.

Start your free trial Already on Pro? Sign in

Filing details

Amount raised: $2,870,000
Offering size: $6,000,000
Investors so far: 14
Minimum investment: $100,000
First sale: October 8, 2024
Securities offered: Equity
Exemption claimed: Rule 506(b)
Industry: Biotechnology
Headquarters: St. Paul, Minnesota
Incorporated: Delaware, 2023
Entity type: Corporation
Revenue range: No Revenues

Filings

Filed	Form	Raised	Offering size	Investors	Source
Sep 25, 2026	D/A (amendment)	$2,870,000	$6,000,000	14	SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Updated September 25, 2026 · Raises in the week of Sep 21, 2026 · Health Care funding in Minnesota · September 2026 funding report

Similar raises

All health care raises →

Technology $15K

Seeweed Inc.

St. Paul, MN · filed Sep 10

First Form DStill raising

Health Care $0

Surgicare of Minneapolis, Ltd.

St. Louis Park, MN · filed Oct 8

7th Form D since 2011

Health CareNo press found $7.5M

Vireo Growth Inc.

Minneapolis, MN · filed Oct 7

Vireo Growth, Inc.'s mission is to provide safe access, quality and value to its customers while supporting its communities through active participation and restorative justice programs. The Company…

17th Form D since 2019

Health Care $10.5M

Piraeus Medical, Inc.

Rochester, MN · filed Oct 7

11th Form D since 2022Still raising

Health Care $520K

Pelvital USA, Inc.

Eagan, MN · filed Oct 5

8th Form D since 2020Still raising

Health Care $5.5M

Evia Bio, Inc.

Minneapolis, MN · filed Sep 28

Evia Bio’s cryopreservation technology enables the entire Cell Therapy supply chain with high product yield, efficacy, and safety. You don’t have to settle for less.

First Form D

Health Care $1.5M

ProEncia Biotechnology Inc.

Woodbury, MN · filed Aug 26

First Form DStill raising

Health Care $1.3M

InSitu Biologics, Inc.

Oakdale, MN · filed Aug 10

InSitu Biologics is advancing localized sustained-release drug delivery, starting with INSB200™, a peripheral nerve block for extended post-surgical pain relief.

6th Form D since 2017Still raising